Tohru Murayama

Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Lymphoid blast crisis in chronic myeloid leukemia after long-term treatment-free remission following imatinib treatment

Lymphoid blast crisis in chronic myeloid leukemia after long-term treatment-free remission following imatinib treatment

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026

Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial.

Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial.

Journal: Transplantation and cellular therapy
Published: March 13, 2026

Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma.

Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma.

Journal: Annals of hematology
Published: January 13, 2026

Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients.

Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients.

Journal: Cancer
Published: December 23, 2025

Clinical hepatic indices serve as predictive markers for sinusoidal obstruction syndrome after allogeneic HSCT.

Clinical hepatic indices serve as predictive markers for sinusoidal obstruction syndrome after allogeneic HSCT.

Journal: International journal of hematology
Published: November 26, 2025

Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Journal: Japanese journal of clinical oncology
Published: May 07, 2025

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Journal: Cancer science
Published: July 11, 2024

Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease.

Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease.

Journal: Bone marrow transplantation
Published: November 02, 2023

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia.

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia.

Journal: EJHaem
Published: May 19, 2023

A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients.

A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients.

Journal: Vaccines
Published: October 10, 2022

The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.

The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.

Journal: Vaccines
Published: December 28, 2021

Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.

Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.

Journal: Hematological oncology
Published: September 16, 2021
Showing 1-12 of 37

Last Updated: 09/26/2026